Medbox, Inc. (OTCQB:MDBX) today issued the following statement in connection with a news release issued yesterday by Medbox shareholder Vincent Mehdizadeh regarding an agreement between Mehdizadeh and Lizada Capital LLC.:

Medbox, Inc., its board of directors and management team are not a party to, nor have they completed the review of an agreement announced yesterday by majority shareholder Vincent Mehdizadeh, which would result in the transfer of the majority of Mehdizadeh’s Medbox shares to Lizada Capital.

Under the agreement, Lizada would purchase a specified number of shares from Mehdizadeh for approximately $15 million, with a total of $5 million of the funds being designated for purchase of Medbox restricted shares of common stock, directly from Medbox. Lizada would become Medbox’s largest shareholder, and a representative of Lizada would join Medbox's board of directors. The transaction has six separate closings over the course of 18 months.

While the Medbox board of directors and management team believe the agreement between Mehdizadeh and Lizada could be favorable to the company and its shareholders, and that Lizada is a viable strategic partner that could assist with fostering the company’s strategic plan, it is still subject to finalization and customary approvals. In addition, while Medbox is open to the proposed $5 million investment in Medbox in exchange for common stock, Medbox is not presently a party to any agreements with respect to that proposal, and the relevant terms and conditions of the proposal would be subject to negotiation and approval by Medbox.

About Medbox, Inc.

Medbox is a leading dispensary and cultivation infrastructure and licensing specialist, patented technology provider, and partner to the cannabis industry. Medbox utilizes its expertise to work with investors and entrepreneurs who seek to enter the cannabis sector, providing them with a high quality turn-key solution, consisting of licensing, site selection, permitting, design, and full build-out. Medbox has become a leader in providing compliance, safety, security, oversight and operational expertise to the medical and recreational cannabis industry nationwide.

Forward-Looking Statements

This statement contains forward-looking statements within the meaning of federal securities laws. Such statements, including, but not limited to, the third-party agreement being favorable to the company and its shareholders, are based on current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond the company’s control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties also include, but are not limited to, technical advances in the industry, as well as political and economic conditions present within the industry. The company does not assume any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made, unless required by law.

PondelWilkinson Inc.Roger Pondel, 310-279-5980pwinvestor@pondel.com